Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,385
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
PEGylated recombinant candida urate oxidase
Sunshine Biopharma
Gout
1 trial -
Pegylated Recombinant Candida Utilis Uricase for Injection
Sunshine Biopharma
Gout
1 trial -
Placebo
Sunshine Biopharma
Healthy
1 trial -
Recombinant erythropoietin stimulating protein
Sunshine Biopharma
Chronic Renal Failure
1 trial -
Recombinant human thrombopoietin
Sunshine Biopharma
Liver Cirrhosis
1 trial -
Rongliflozin
Sunshine Biopharma
Type 2 Diabetes Mellitus
1 trial -
SPGL008
Sunshine Biopharma
Advanced Malignant Tumors
1 trial -
SSGJ-612
Sunshine Biopharma
Advanced Malignant Tumors
1 trial -
SSGJ-613
Sunshine Biopharma
Systemic Juvenile Idiopathic Arthritis
1 trial -
SSGJ-613
Sunshine Biopharma
Arthritis, Gouty
1 trial -
SSGJ-705
Sunshine Biopharma
Receptor, ErbB-2
1 trial -
SSGJ-706
Sunshine Biopharma
Advanced Solid Tumors Patients
1 trial -
SSGJ-709
Sunshine Biopharma
Advanced Malignant Tumors
1 trial -
SSS11
Sunshine Biopharma
Gout
1 trial -
SSS17
Sunshine Biopharma
Anemia in Chronic Kidney Diseases
2 trials -
SSS17
Sunshine Biopharma
Healthy Subjects (HS)
1 trial -
SSS39
Sunshine Biopharma
Safety and Tolerability in Healthy Volunteers
1 trial -
SSS55
Sunshine Biopharma
Safety Issues
1 trial -
SSS59
Sunshine Biopharma
Malignant Tumors
1 trial -
SSS67 Injection
Sunshine Biopharma
Healthy
1 trial -
Yimitasvir Phosphate
Sunshine Biopharma
Hepatic Impairment
1 trial -
Yimitasvir Phosphate Capsule
Sunshine Biopharma
Renal Impairment
1 trial -
Z650
Sunshine Biopharma
Pancreatic Cancer
1 trial -
[14C] Antaitavir Hasophate
Sunshine Biopharma
Healthy Male Subjects
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources